Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

EBR:TESB - Euronext Brussels - BE0003555639 - Common Stock - Currency: EUR

25.75  +0.2 (+0.78%)

Fundamental Rating

5

TESB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Chemicals industry. TESB has an average financial health and profitability rating. TESB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year TESB was profitable.
In the past year TESB had a positive cash flow from operations.
TESB had positive earnings in each of the past 5 years.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of TESB (1.46%) is comparable to the rest of the industry.
TESB has a Return On Equity of 2.26%. This is comparable to the rest of the industry: TESB outperforms 54.84% of its industry peers.
TESB has a Return On Invested Capital of 2.05%. This is comparable to the rest of the industry: TESB outperforms 51.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TESB is in line with the industry average of 6.15%.
The last Return On Invested Capital (2.05%) for TESB is well below the 3 year average (6.25%), which needs to be investigated, but indicates that TESB had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROIC 2.05%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.62%, TESB is in line with its industry, outperforming 54.84% of the companies in the same industry.
In the last couple of years the Profit Margin of TESB has declined.
TESB's Operating Margin of 2.41% is in line compared to the rest of the industry. TESB outperforms 46.77% of its industry peers.
TESB's Operating Margin has declined in the last couple of years.
TESB has a worse Gross Margin (19.38%) than 67.74% of its industry peers.
In the last couple of years the Gross Margin of TESB has declined.
Industry RankSector Rank
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TESB is destroying value.
The number of shares outstanding for TESB has been reduced compared to 1 year ago.
TESB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TESB is higher compared to a year ago.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.03 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.03, TESB is in line with its industry, outperforming 50.00% of the companies in the same industry.
TESB has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
TESB has a better Debt to FCF ratio (1.69) than 95.16% of its industry peers.
TESB has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
TESB has a better Debt to Equity ratio (0.07) than 91.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Altman-Z 2.03
ROIC/WACC0.28
WACC7.24%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

TESB has a Current Ratio of 2.11. This indicates that TESB is financially healthy and has no problem in meeting its short term obligations.
TESB's Current ratio of 2.11 is fine compared to the rest of the industry. TESB outperforms 69.35% of its industry peers.
A Quick Ratio of 1.18 indicates that TESB should not have too much problems paying its short term obligations.
TESB has a Quick ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.46%.
The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
The Revenue has decreased by -9.58% in the past year.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%

3.2 Future

TESB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.03% yearly.
TESB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue Next Year7.68%
Revenue Next 2Y5.78%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.87, which means the current valuation is very expensive for TESB.
TESB's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.87, TESB is valued a bit more expensive.
With a Price/Forward Earnings ratio of 16.08, TESB is valued correctly.
66.13% of the companies in the same industry are more expensive than TESB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.38. TESB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 37.87
Fwd PE 16.08
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

TESB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TESB is cheaper than 87.10% of the companies in the same industry.
87.10% of the companies in the same industry are more expensive than TESB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.15
EV/EBITDA 5.35
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

TESB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y33.42%
EPS Next 3Y11.03%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 2.08%.
TESB's Dividend Yield is comparable with the industry average which is at 3.07.
Compared to an average S&P500 Dividend Yield of 2.46, TESB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

On average, the dividend of TESB grows each year by 6.16%, which is quite nice.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years1
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

TESB pays out 126.17% of its income as dividend. This is not a sustainable payout ratio.
TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP126.17%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TESB.BR Dividend Payout.TESB.BR Dividend Payout, showing the Payout Ratio.TESB.BR Dividend Payout.PayoutRetained Earnings

TESSENDERLO GROUP

EBR:TESB (4/28/2025, 7:00:00 PM)

25.75

+0.2 (+0.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)08-19 2025-08-19
Inst Owners4.44%
Inst Owner ChangeN/A
Ins Owners47.46%
Ins Owner ChangeN/A
Market Cap1.55B
Analysts78
Price Target28.56 (10.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP126.17%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.7%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.9%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.89%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 16.08
P/S 0.59
P/FCF 10.15
P/OCF 4.65
P/B 0.82
P/tB 0.98
EV/EBITDA 5.35
EPS(TTM)0.68
EY2.64%
EPS(NY)1.6
Fwd EY6.22%
FCF(TTM)2.54
FCFY9.85%
OCF(TTM)5.54
OCFY21.51%
SpS44.01
BVpS31.52
TBVpS26.21
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 2.26%
ROCE 2.73%
ROIC 2.05%
ROICexc 2.3%
ROICexgc 2.71%
OM 2.41%
PM (TTM) 1.62%
GM 19.38%
FCFM 5.76%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.69
Debt/EBITDA 0.49
Cap/Depr 85.39%
Cap/Sales 6.82%
Interest Coverage 7.01
Cash Conversion 121.03%
Profit Quality 356.54%
Current Ratio 2.11
Quick Ratio 1.18
Altman-Z 2.03
F-Score6
WACC7.24%
ROIC/WACC0.28
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-60.46%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-162.24%
EPS Next Y39.56%
EPS Next 2Y33.42%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%-3.32%
Revenue Next Year7.68%
Revenue Next 2Y5.78%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y-46.88%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year303.65%
EBIT Next 3Y60.06%
EBIT Next 5YN/A
FCF growth 1Y274.94%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y52.01%
OCF growth 3Y10.33%
OCF growth 5Y8.69%